Trademark: 79328331
Word

Status
Registered
Status Code
700
Status Date
Tuesday, October 11, 2022
Serial Number
79328331
Registration Number
6868479
Registration Date
Tuesday, October 11, 2022
Mark Type
2000
Filing Date
Monday, October 25, 2021
Published for Opposition
Tuesday, July 26, 2022

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The mark consists of a three-dimensional, partially rounded band with concave ends tilted up and to the right partially encircling three, three-dimensional ovals each separated by three, three-dimensional circles that diminish in size and extend up and to the right of the opening in the band; the largest innermost oval has a circle on its upper left quadrant and it and the other ovals slightly overlap the first and third circles that separate each oval; the color grey is intended to show shading or contrast only and is not a feature of the mark.

Trademark Events
Feb 21, 2023
Final Decision Transaction Processed By Ib
Feb 2, 2023
Final Disposition Notice Sent To Ib
Feb 1, 2023
Final Disposition Processed
Jan 11, 2023
Final Disposition Notice Created, To Be Sent To Ib
Oct 11, 2022
Notice Of Registration Confirmation Emailed
Oct 11, 2022
Registered-Principal Register
Jul 26, 2022
Notification Processed By Ib
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 6, 2022
Notification Of Possible Opposition Sent To Ib
Jul 6, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 21, 2022
Approved For Pub - Principal Register
Jun 6, 2022
Assigned To Examiner
May 23, 2022
Teas/Email Correspondence Entered
May 23, 2022
Correspondence Received In Law Office
May 23, 2022
Teas Response To Office Action Received
May 1, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 1, 2022
Teas Change Of Correspondence Received
May 1, 2022
Teas Change Of Domestic Representatives Address
May 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 1, 2022
Teas Change Of Owner Address Received
Mar 27, 2022
Refusal Processed By Ib
Mar 8, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 7, 2022
Refusal Processed By Mpu
Feb 9, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 8, 2022
Non-Final Action Written
Feb 7, 2022
Assigned To Examiner
Jan 4, 2022
Application Filing Receipt Mailed
Dec 30, 2021
New Application Office Supplied Data Entered
Dec 27, 2021
Limitation From Original Application Entered
Dec 16, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24